CUSIP G8807B106COMTBPHQ4 2025
53 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Madison Avenue Partners, LP | 9.51M | $177.95M |
| 2 | Weiss Asset Management LP | 7.46M | $139.52M |
| 3 | Newtyn Management, LLC | 4.30M | $80.45M |
| 4 | Blackrock, Inc. | 4.05M | $75.79M |
| 5 | Irenic Capital Management LP | 2.76M | $51.66M |
| 6 | Vanguard Group Inc | 2.37M | $44.29M |
| 7 | D. E. Shaw & Co., Inc. | 1.26M | $23.57M |
| 8 | State Street Corp | 1.10M | $20.62M |
| 9 |
| 4 | Nov 14, 2024 | Madison Avenue Partners, LP | 13G/A | 19.4% | 9.51M | SEC |
| 5 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 6 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 8 | Sep 9, 2024 | Baupost Group LLC/Ma | 13G/A | — | — | SEC |
| 9 | Aug 16, 2024 | Newtyn Management, LLC | 13G | 8.4% | 4.10M | SEC |
| 10 | Aug 9, 2024 | Baupost Group LLC/Ma | 13G/A | 6.1% | 2.98M | SEC |
See the full Schedule 13D/13G history for Theravance Biopharma Inc.
Unlock full history| 963.3K |
| $18.02M |
| 10 | Geode Capital Management, LLC | 938.7K | $17.57M |